Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Mixed Results In AZ's DECLARE-TIMI 58 CV Trial Cloud Implications For Farxiga
Sep 24 2018
•
By
Sten Stovall
Farxiga showed mixed results in Its Phase III DECLARE-TIMI 58 CV Trial • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Clinical Trials
More from R&D